- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01643564
Cytokine Profiling Post-Heart Transplant
October 2, 2023 updated by: University of Minnesota
Cytokine Profiling of Cardiac Transplant Recipients
Measurement of cytokine levels in post-cardiac transplant patients with unexplained graft dysfunction.
Study Overview
Status
Terminated
Conditions
Study Type
Observational
Enrollment (Actual)
34
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Cardiology Clinic and inpatient service.
Normal controls are volunteers from within the community.
Description
Inclusion Criteria:
Group 1
- 18 years and older
- Cardiac Transplant recipient with graft dysfunction of unknown etiology
Group 2
- 18 years or older
- No history of heart failure or cardiac transplantation Group 3
- 18 years or older
- Class II-IV heart failure Group 4
- 18 years or older
- Heart Transplant 6 months or greater prior to blood draw
- No graft dysfunction
Exclusion Criteria:
Group 1 Heart Transplant with Unexplained Graft Dysfunction
- Cellular or antibody-mediated cardiac allograft dysfunction
Group 2 Normal Control group
- Active infection within 1 month of blood draw
- Known Inflammatory Disease
Group 3 Heart Failure Group
- Active infection within 1 month of blood draw
- Known Inflammatory Disease
Group 4 Heart Transplant with Normal Graft Function Group
- Active infection within 1 month of blood draw
- Known graft dysfunction
- Known Inflammatory Disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group 1
Heart Transplant Recipients with Unexplained Graft Dysfunction
|
|
Group 2
Normal Control
|
|
Group 3
Class III-IV Heart Failure
|
|
Group 4
Heart Transplant Recipients with Normal Graft Function
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection
Time Frame: 12 months
|
Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Peter M Eckman, MD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
July 16, 2012
First Submitted That Met QC Criteria
July 17, 2012
First Posted (Estimated)
July 18, 2012
Study Record Updates
Last Update Posted (Actual)
October 4, 2023
Last Update Submitted That Met QC Criteria
October 2, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1111M06547
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Transplant
-
Stanford UniversityKaiser Foundation Research InstituteCompletedLung Transplant Rejection | Cardiac Transplant RejectionUnited States
-
Barry A. BoilsonJanssen Biotech, Inc.Enrolling by invitation
-
Mayo ClinicRecruitingCardiac Transplant RejectionUnited States
-
Baylor Research InstituteCompleted
-
Carnegie Mellon UniversityCompleted
-
University of AlbertaRecruitingCardiac Transplant DisorderAustralia, Austria, Canada, Czechia, France, United States, Italy, Spain
-
Carnegie Mellon UniversityCompleted
-
Carnegie Mellon UniversityCompleted
-
Carnegie Mellon UniversityCompleted
-
National Taiwan University HospitalCompletedCardiac Transplant DisorderTaiwan